THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SOLIFENACIN SUCCINATE IN PATIENTS WITH MILD, MODERATE, AND SEVERE RENAL DISEASE
Smulders R1, Smith N2, Krauwinkel W1, Balan G3 1. Yamanouchi Europe B.V., 2. Yamanouchi Pharma America, Inc., 3. Covance, Inc.
|
|
Abstract 303
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 16
|
|
|